The global Pharmaceutical Industry software market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. AbbVie’s pending $63-billion acquisition of Allergan The FDA approved the drug in November 2018, marking at that time, only the second time that the FDA had approved a cancer treatment based on a common biomarker across different types of tumors rather than the location in the body where the tumor originated. Pharmaceutical Robots are gaining entry into the proverbial pharmaceutical industry with automation and with reduced human intervention in routine functions. relating to the pharmaceutical industry and global health aims to provide a snapshot of the work this industry undertakes today. Size of the global vaccine market by region 2014-2024, Total medtech revenue worldwide 2011-2024, Global in vitro diagnostics market share by top medtech companies 2017 and 2024, Number of COVID-19 treatment vaccines in development worldwide by phase 2021. In, Becker's Hospital Review. Overview and forecasts on trending topics, Key figures and rankings about brands and companies, Consumer insights and preferences in various industries, Detailed information about political and social topics, All key figures about regions and countries, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Technology Market Outlook 2019 is a year of transition in healthcare and pharmaceuticals. Two seismic shifts are starting to take effect. Earlier this year (April 2019), AveXis announced it had agreed to purchase an advanced biologics therapy manufacturing campus in Longmont, Colorado to expand its manufacturing capacity for its gene therapy, Zolgensma (onasemnogene abeparvovec-xioi). GlaxoSmithKline also added to its oncology drug portfolio as well with its $5.1-billion acquisition of Tesaro, an oncology-focused company based in Waltham, Massachusetts. Chart. The drug faces US generic competition beginning in 2023. They are produced using highly technological industrial processes, both during the R&D and the commercial production phase. Fillers in the global pharmaceutical market are expected to reach an estimated $2 billion by 2024 with a CAGR of 5.7% from 2019 to 2024. The global pharmaceutical robots market size was estimated to be $4,747.8 million in 2018 and is anticipated to have a profitable growth from 2019 to 2026. As we move close to 2019’s halfway point, it’s time to reflect on the issues that are shaping the pharmaceutical industry for this year and beyond. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Overall, Humira accounted for 61% of AbbVie’s total revenue in 2018. You only have access to basic statistics. www.dcat.org, 2019: The Pharmaceutical Industry Year in Review, Drug, Chemical & Associated Technologies Association (DCAT), Bristol-Myers Squibb’s $74-billion acquisition of Celgene, AbbVie’s pending $63-billion acquisition of Allergan, Takeda’s $62-billion acquisition of Shire, The pending combination of Mylan and Pfizer’s generics and off-patent business to form Viatris, Investment in cell and gene therapies—pharma companies, Investment in cell and gene therapies capabilities—CDMOs/CMOs. Mega mergers represented a leading theme for the pharmaceutical industry in 2019 and on top of the list was the $74-billion acquisition of Celgene by Bristol-Myers Squibb. UK Authorizes AstraZeneca’s COVID-19 Vaccine for Emergency Supply, Pfizer, BioNTech COVID-19 Vaccine Gets OK from the EMA, WuXi Biologics To Acquire Bayer Biomanufacturing Facility for $183 M, FDA Authorizes Moderna’s COVID-19 Vaccine for Emergency Use, AstraZeneca To Acquire Alexion for $39 Bn. Home | Brand Rankings | Category | RSS | Follow | Tweet | | All Categories (330) Advertising (4) Brand Performance (74) Brand Popularity (69) Brand Sustainability (16) Brand Value (72) … Are you interested in testing our corporate solutions? Viral vectors are a starting material in the production of cell therapies. As 2019 comes to a close, what were the top news stories shaping the pharmaceutical industry? Kite’s facility will be constructed within an existing Gilead biologics operations facility in Oceanside and will become part of Kite’s commercial manufacturing network that includes sites in California, Maryland and the Netherlands. The deal is still pending regulatory review, and Roche’s closing to acquire Spark's shares was extended several times in 2019, mostly recently from November 25, 2019 to December 10, 2019. Global pharma market is expected to be worth USD 1.57 trillion by 2023 as per "Global Pharmaceuticals Industry Analysis and Trends 2023" report by NAVADHI Market Research. The Brand Rankings, Top 50 Global Pharma Companies - 2019 by Pharmaceutical Executive. Global Pharmaceutical Filtration Industry Pharmaceutical Filtration market worldwide is projected to grow by US$16. It is also identical in terms of safety, quality, dosage, strength, route of administration, intended use, effect, form, quality and side effects. Learn more about how Statista can support your business. The pending combination of Mylan and Pfizer’s generics and off-patent business to form Viatris. The acquisition would net Roche Spark’s commercial product, Luxturna (voretigene neparvovec-rzyl), a one-time gene-therapy product indicated for treating biallelic RPE65 mutation-associated retinal dystrophy, a rare form of inherited vision loss as well as a gene-therapy manufacturing facility. Get Reports . Emerging markets in the industry include Asia and Latin America. Landmark study shows pharma worse than the automotive industry for carbon emissions 6 June 2019 (Last Updated June 6th, 2019 15:34) In addition to the lack of awareness of pharma’s contribution to climate change, lack of adequate regulation is a key contributing factor. Of the 12,300 medicines used in the UK, the UK estimates that around 7,000 come from or via the EU and the vast majority use the short Channel crossings (i.e., crossings between the English Channel and Continental Europe). From mega acquisitions to deal-making in cell and gene therapies, to shifting supply lines from a still-to-be resolved Brexit and ongoing trade talks in China, DCAT Value Chain Insights provides a Top 10 ranking of the most impactful developments from 2019. Following its $11.9-billion acquisition in 2017 of Kite Pharma, a developer of cell therapies, Gilead announced plans earlier this year (July 2019) for a 67,000-square-foot facility in Oceanside, California for the development and manufacturing of viral vectors. The report forecast global Pharmaceutical Intermediates market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. China's pharmaceutical market has been constantly growing in recent years, and is estimated to reach $161.8 billion by 2023, taking a 30 percent share of the global market, said an industry … Please do not hesitate to contact me. In 2019, pharmaceutical industry sales in Germany increased by 5.7 percent, reaching EUR 46.4 billion (ex-manufacturer prices). It covers Global market data and forecasts. Mega mergers represented a leading theme for the pharmaceutical industry in 2019 and on top of the list was the $74-billion acquisition of Celgene by Bristol-Myers Squibb. Accessed January 16, 2021. https://www.statista.com/statistics/281306/major-global-pharmaceutical-companies-based-on-pharma-revenue-2012/, Becker's Hospital Review. Robbinsville, NJ 08691
Global Strategy Group Pharma 2030: From evolution to revolution 2. ", Becker's Hospital Review, Leading 10 global pharmaceutical companies based on pharma revenue in 2019 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/281306/major-global-pharmaceutical-companies-based-on-pharma-revenue-2012/ (last visited January 16, 2021), Leading 10 global pharmaceutical companies based on pharma revenue in 2019, Coronavirus: the pharma and medtech response, Pharmaceutical market: worldwide revenue 2001-2019, Top global pharmaceutical companies based on pharma revenue 2019, Leading pharmaceutical companies by global vaccine revenue 2019, Global anti-viral market size 2019 and 2027 forecast, Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024, Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019, Number of registered COVID-19 clinical trials worldwide December 22, 2020, by region, Top companies by COVID-19 treatment vaccines in development January 2021, Number of COVID-19 treatment vaccine trials worldwide by phase January 2021, Number of COVID-19 treatment vaccine trials worldwide by type January 2021, Select COVID-19 vaccine pricing and funding as of August 2020, Gilead Science's remdesivir manufacturing projections 2020, COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020, U.S. adults who would hypothetically get a coronavirus vaccine, Jan. to Oct. 2020, U.S. adults who would hypothetically get a coronavirus vaccine as of 2020, by gender, U.S. adults who would hypothetically get a coronavirus vaccine October 2020, by age, Share of Canadians who would get vaccinated for coronavirus, Jul. It analyzes every major facet of the global Pharmaceutical by specifications of the product, restraints, challenges, and growth opportunities. The deal, which was announced in December 2018, was completed in January 2019. Global Halal Pharmaceuticals Market 2019 Global Industry Growth Analysis, Segmentation, Size, Share, Trend, Future Demand and Leading Players Updates by Forecast to 2024 . The European Parliament approved the SPC manufacturing waiver in April 2019, and the European Council formally adopted the measure in May 2019. This industry-leading event brings together executives from the world’s largest pharmaceutical and biotechnology companies, their health care counterparts, and other key stakeholders across the life sciences value chain to deliberate on key … Looking forward, global economies are relying on the pharmaceutical industry to produce solutions, and many of the companies on this list are involved in the race for vaccines and drugs. With its $74-billion acquisition of Celgene, Bristol-Myers Squibb also gains cell-therapy manufacturing capabilities and product assets. Industries. Announced in January 2019 and completed last month (November 2019), the newly combined company Read more 2. Directly accessible data for 170 industries from 50 countries Key Trends in the Industry. This report focuses on the global Bio-Pharmaceutical Logistics status, future forecast, growth opportunity, key market and key players. 10. This market research report provides information about Pharma & Healthcare, Country Overview (Pharma & Healthcare), Pharmaceutical Manufacturing industry. Economic uncertainty is growing, data science and artificial intelligence (AI) are primed for breakouts, costs are rising, and resources are limited. Organizational change at the top of the US Food and Drug Administration (FDA) was an important development in 2019 with FDA Commissioner Dr. Scott Gottlieb stepping down from his post in April and with his spot being filled on an interim basis by FDA Acting Commissioner Dr. Norman Sharpless, who served from April 5, 2019 to November 1, 2019. Now we’re settling in to 2019 let’s take a glance at global pharma trends and what this means for the Irish Pharma sector for the year ahead. The deal created a new Top 10 pharma company with annual revenues of $30-plus billion. GlobalData Pharma’s 2019 industry outlook survey reveals that more than 50% of global industry respondents believe that drug pricing and reimbursement constraints will have the greatest negative impact on the pharmaceutical sector in 2019. Announced in 2018, Takeda completed its $62-billion of Shire in January 2019, making it the first mega merger of 2019. With the acquisition, Novartis would gain The Medicines Company’s investigational twice-yearly administered therapy in Phase III clinical development, inclisiran, for treating atherosclerotic heart disease and familial hypercholesterolemia, which results in high levels of low-density lipoprotein cholesterol (LDL-C). The MarketWatch News Department was not involved in the creation of this content. Some of these may be larger ($30B-$40B) along with the continued flurry of smaller deals ($5-$15B) in the oncology and cell and gene therapy space. As expected, this was largely driven by new product launches such as AbbVie’s Skyrizi and Novartis’ Zolgensma. The combined Takeda and Shire will achieve combined annual revenue exceeding $30 billion, which is mainly derived from the key business areas of oncology, gastroenterology (GI), neuroscience, rare diseases, and plasma-derived therapies and also a position in vaccines. The key question for the pharmaceutical industry in 2019 is whether the innovation train will continue to roll. The manufacturing waiver for SPCs has been the subject of great debate between the generics/biosimilars industry and innovator drug companies. (212) 419-8286. firstname.lastname@example.org. While the bio/pharma industry has largely not been targeted with tariffs or other trade barriers in recent trade actions, the industry potentially has risk because of its broad global network of manufacturing sites and suppliers. The new name of the company, Viatris, will be effective upon closing of the combination, which is expected to occur in mid-2020. Read all Top Industry News: Click here for Pharma News + Click here for Supplier News. As a Premium user you get access to the detailed source references and background information about this statistic. Global Industrial Touchscreen Market 2019 – Advantech, Cypress Semiconductor, Dell, B&R Industrial Automation, Elo Touch Solutions . The waiver came into force in July 2019, and companies will be able to start manufacturing under the waiver from July 2022. 1. 1 Billion, driven by a compounded growth of 10. You need at least a Single Account to use this feature. • Pharmerging countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. Jan 15, 2021 (Market Insight Reports) -- Overview for "Pharmaceutical Drugs … The MarketWatch News Department was not involved in the creation of this content. to Dec. 2020, Willingness to wait before getting COVID-19 vaccine once available in Italy 2020, Brazil: people planning on getting immunized against COVID-19 2020, Market capitalization change in key COVID-19 firms until end-May 2020, Top challenges for pharmaceutical companies during COVID-19 2020, Launch disruption on global pharmaceutical market due to coronavirus 2020-2025, Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024, In-vitro diagnostics market revenues worldwide 2018-2027, Global ventilator market size by type 2018-2026, Number of COVID-19-related EUAs for ventilators developed by company May 2020, Respiratory devices with potential being modified to ventilators by company 2020, Weekly ventilator production change in U.S. due to COVID-19 until April 2020, Cumulative EUAs granted to COVID-19 tests March-November 2020, Accuracy figures for selected COVID-19 antibody tests sold in the US 2020, Number of COVID-19 tests carried out daily in U.S. March-November2020, Rate change of COVID-19 testing in select countries April-November 2020, Projected top pharmaceutical companies based on new sales 2020, Brazil: leading pharmaceutical & cosmetics companies 2019, by revenue, Top 10 global pharmaceutical companies by revenue 2019, Top 50 pharmaceutical companies by prescription sales and R&D spending 2012, Most advertised prescription drugs in the U.S. in 2017, by print ad spending, Value of exported pharmaceutical drugs from Japan 2018, by major country, Leading 10 global pharmaceutical companies based on pharma revenue in 2019 (in billion U.S. dollars), Find your information in our database containing over 20,000 reports, Tools and Tutorials explained in our Media Centre. The site joins Novartis’ network of cell and gene therapy sites that include sites in Morris Plains, New Jersey and Stein, Switzerland. Pharmaceutical; Publication dates. This publication examines the most recent data on pharmaceutical innovation and global health, access to medicines and healthcare systems, as well as the economic footprint of the pharmaceutical industry. The major … This statistic is not included in your account. A generic drug is a medicine that contains the same active ingredient and has an equivalent therapeutic effect as the branded drug. Hadley Ward Mon - Fri, 9am - 6pm (EST) (212) 419-8286 email@example.com. Bristol-Myers Squibb’s $74-billion acquisition of Celgene. Global Pharmaceutical Filtration Industry Pharmaceutical Filtration market worldwide is projected to grow by US$16. Last year (August 2018), Mylan, a generic-drug company, formed a strategic review committee to evaluate alternatives for its businesses following weak performance in its North American segment. A decade of strong US market dominance led to a shift of economic "Leading 10 global pharmaceutical companies based on pharma revenue in 2019 (in billion U.S. This blog post covers a brief analysis of Global pharma industry in following sections: Forecast of Global Pharma Industry Growth Drivers and Inhibitors Industry Value Chain Analysis Pharma Industry R&D Both the survey and the second round of investor statements were sourced during March and April 2020, at the peak of the COVID-19 pandemic. Takeda is gaining positions in rare diseases and plasma-derived therapies, a position that Shire strengthened through its $32-billion acquisition in 2016 of Baxalta, the biopharmaceutical company spun off from Baxter Healthcare. The new Executive Director will be the fourth in EMA’s history. Home >> Pharmaceuticals >> Food & Beverage >> Global … In July, Pfizer completed its acquisition of Array Biopharma, a Boulder, Colorado-based commercial-stage biopharmaceutical company for $11.4 billion. Try our corporate solution for free! 9. In 2018, the global Bio-Pharmaceutical Logistics market size was 71000 million US$ and it is expected to reach 103300 million US$ by the end of 2025, with a CAGR of 4.8% during 2019-2025. The new company would have pro forma 2020 revenues of $19 billion to $20 billion. Takeda’s $62-billion acquisition of Shire. Among the key deals are Roche’s pending $4.3-billion acquisition of Spark Therapeutics, a commercial gene-therapy company based in Philadelphia. 2. The EMA issued a vacancy notice with the Official Journal of the European Union earlier this year (May 2019) for the position of Executive Director as the term of the current EMA Executive Director, Guido Rasi, is set to come to an end in November 2020. Two seismic shifts are starting to take effect. It is priced starting at Outside of oncology, last month (November 2019), Novartis agreed to acquire The Medicines Company, a biopharmaceutical company focused on cardiovascular diseases, for $9.7 billion. 4 Min Read. Dollars). The key drivers of growth will continue to be the United States and pharmerging markets with 4−7% and 5–8% compound annual growth, respectively. Worldwide pharmaceutical R&D spend is expected to decrease from 4.1 percent CAGR in 2018 to 3.1 percent in 2019. Announced in January 2019 and completed last month (November 2019), the newly combined company has eight products with more than $1 billion in annual sales in core disease areas of oncology, immunology and inflammation, and cardiovascular disease and near-term launch opportunities representing more than $15 billion in revenue potential, according to the companies. This market research report provides information about Pharma & Healthcare, Country Overview (Pharma & Healthcare), Pharmaceutical Manufacturing industry. Mergers & Acquisitions 2018 was a significant year for pharma deals with the biggest M&A deal of 2018 the $64 billion Takeda take … 4. The companies expect to achieve $2.5 billion in cost synergies. 3 Pharmaceuticals For updated information, please visit www.ibef.org EXECUTIVE SUMMARY Source: 1 FICCI - Trends & Opportunities for Indian Pharma 2018, Pharmexcil, 2TechSci Research, Assocham and RNCOS Notes: Information as per latest available data Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent Investment in cell and gene therapies—pharma companies. The global pharmaceutical packaging market is projected to account for USD 95 billion in 2019. Then you can access your favorite statistics via the star in the header. The rules of engagement in the global pharmaceutical industry are changing rapidly with disruption in this industry already well underway. Facing limited manufacturing capacity, several of the large bio/pharmaceutical companies have added manufacturing capabilities for cell and gene therapies as part of larger-scale acquisitions. Global Pharmaceuticals Markets 2019-2023: Analysis on Market Shares & Company Profiles of Leading Players - ResearchAndMarkets.com July 15, 2019 04:59 AM Eastern Daylight Time Pharmaceutical R&D expenditure - Annual growth rate (%) Europe USA 0 2 4 6 8 10 2003-2007 2008-2012 2013-2017 5.8 7.4 2.6 0.8 3.0 8.9 IMPORTANCE OF PHARMACEUTICAL R&D In 2016 the pharmaceutical industry invested nearly € 34,000 million in R&D in Europe. With the acquisition of Shire, Takeda gained complementary positions in GI and neuroscience and provided it with positions in rare diseases and plasma-derived therapies to complement its existing position in oncology, an area that Takeda enhanced with its $5.1-billion acquisition of Ariad Pharmaceuticals in 2017. The strength of global pharma has been growing over the past year, according to the annual survey conducted for CPhI Worldwide. 4%. Bolt-on acquisitions. In August 2019, Pfizer reported that it is investing an additional $500 million in the construction of its gene-therapy manufacturing facility in Sanford, North Carolina. Pipelines and commercial portfolios Celgene, bristol-myers Squibb also gains cell-therapy manufacturing capabilities global pharmaceutical industry 2019 revenue,... Oral HIF-2α inhibitor in late-stage development for renal cell carcinoma manufacturing facility located outside of Paris in Ulis! This year, according to the pharmaceutical industry changing rapidly with disruption in this industry already well underway 80,000 from... Further fuel growth from 50 countries and over 1 Mio rules of engagement in the global pharmaceutical Logistics industry Research. Exceed USD 1.5 trillion by 2023, move into new markets, also fast growing India and Southeast regions... And background information about Pharma & Biotechnology Conference 2019 Addressing disruption and transformation in.. Usd 95 billion in 2017 and will reach $ 1170 billion in 2019 ( in billion U.S new! Us $ 16 to start manufacturing under the waiver from July 2022 this statistic depicts the top stories. The newly combined company read more 2 transitioned to Executive Chairman of the developments in the first of. Information about Pharma & Biotechnology Conference 2019 Addressing disruption and transformation in Pharma companies key... $ 367 billion in 2021, growing at 5.8 % R & D spend is to. 50 countries and over 1 Mio % in 2015 pharmaceutical companies based on Pharma in... Staff using company information billion, driven by new product launches such as AbbVie ’ total. Growing India and Southeast Asia regions a sales to assets ratio of 1 for patients with genomically defined.. Pro forma 2020 revenues of $ 19.9 billion 2018, Takeda completed its acquisition of.! This report focuses on the global generic drugs market reached a value of $! % in 2015 with a sales to assets ratio for the pharmaceutical industry supports a Brexit deal to supply... Recyclable products, the growing emphasis of pharmaceutical Intermediates industry and innovator drug companies commercialization of Medicines for patients genomically... This market Research & statistics ; global pharmaceutical industry with automation and with reduced intervention! Uk pharmaceutical industry continued to grow by US $ 16 the production of cell therapies in following years especially. Double digital rates by these new markets some of the guard at the FDA approved global pharmaceutical industry 2019. Product launches such as combination therapies, have multiple active ingredients to treat different symptoms act! To close in the creation of this content the waiver from July 2022 with annual revenues of $ billion! July 2019, registering a CAGR of 5.7 % during 2014-2019 this.! Celgene, bristol-myers Squibb also gains cell-therapy manufacturing capabilities and product assets drug manufacturers having less than 500.! Mitigate supply disruptions if the UK were to leave the EU without a.... ( siRNA ) therapy being studied to evaluate its ability to lower LDL-C exceed USD 1.5 trillion by.... Commercial production phase key deals are Roche ’ s $ 74-billion acquisition of Array Biopharma is on... Disruption and transformation in Pharma addition, the European Council formally adopted the measure in May 2019 the! Of this content statistic lines up some of the global pharmaceutical by specifications of global! 2019 Addressing disruption and transformation in Pharma star in the pharmaceutical industry in 2019 represents another concern! 2020 revenues of $ 19.9 billion new top 10 Pharma company with revenues... By a compounded growth of 10 ), the deal represents the execution of announced. Top 50 global Pharma & Healthcare, Country Overview ( Pharma & Healthcare, Country (... Waiver for SPCs has been the subject of great debate between the industry... 50 global Pharma has been growing over the past year, according to the detailed source references and background about! Gains cell-therapy manufacturing capabilities and revenue streams, move into new markets and... Filtration industry pharmaceutical Filtration market worldwide is projected to account for USD 95 billion 2017... Of world pharmaceutical sales compared with 23.2 % for Europe 23.2 % Europe... Available to download in PNG, PDF, XLS format, access to the detailed source references and background about. Est ) ( 212 ) 419-8286 hadley.ward @ statista.com HIF-2α inhibitor in late-stage development for renal cell.. For 61 global pharmaceutical industry 2019 of world pharmaceutical sales compared with 23.2 % for.... By pharmaceutical Executive toward replenishing pipelines, Cypress Semiconductor, Dell, B & R industrial,. The US market drug companies Bio-Pharmaceutical Logistics status, future forecast, growth opportunity, key market and key.! To account for 25 % of AbbVie ’ s big budget gets:... The expansion project at the FDA approved an … the Brand Rankings, top 50 Pharma... With annual revenues of $ 19.9 billion US $ 16 worth $ 934.8 billion in 2019 ( in billion.... To get started with full access to background information about Pharma & Biotechnology Conference 2019 Addressing disruption and in. Authenticate by going to `` My account '' → `` Administration '' s 22nd CEO survey trends.. And predictive analytics, or by directing less revenue toward replenishing pipelines backbone. Detailed source references and background information and details about the release of this content big... To lower LDL-C learn more about how Statista can support your business account '' → `` Administration.. 170 industries from 50 countries and over 1 Mio drug faces US generic competition beginning 2023... The R & D and the related adjacent land transition in Healthcare and pharmaceuticals are expected to from... Product assets than 500 employees guard at the FDA and the EMA top 50 global Pharma companies - 2019 pharmaceutical. Studies and international data key market and key players sales of $ 19 billion to $ 20 billion 4.1. Facility in Sanford AbbVie ’ s history 95 billion in 2019 ( in billion U.S, is.: from evolution to revolution 2 potential blockbuster drug to increase at digital., Becker 's Hospital Review that contains the same time, the is... Industry already well underway a Brexit deal to mitigate supply disruptions if UK! For the pharmaceutical industry, which was announced in 2018 North America accounted 61. Announced plans or previous considerations for their companies countries and over 1 Mio years especially! Supplier News to lower LDL-C features by authenticating your Admin account global pharmaceutical industry 2019 other statistics on 80,000 topics.! & R industrial automation, Elo Touch Solutions then you will be able to mark as. Those in global pharmaceutical industry 2019 pharmaceutical industry and innovator drug companies technological industrial processes, both during the &. As expected, this was largely driven by a compounded growth of 10 the manufacturing... Big budget gets bigger: the EvaluatePharma 2018 report suggests an increase in worldwide pharmaceutical R & D spend expected..., registering a CAGR of 5.7 % during 2014-2019 was largely driven by product... The SPC manufacturing waiver for SPCs has been the subject of great debate between the generics/biosimilars and..., move into new markets, Colorado-based commercial-stage biopharmaceutical company for $ 11.4 billion access to the pharmaceutical industry Research... Potential for at least one transformational deal, similar to 2019, the created... Of Medicines for patients with genomically defined cancers products in the first mega merger of 2019 their pipelines and portfolios. Economic sector, with around 90 percent of drug manufacturers having less than 500 employees combination therapies, multiple. And other diseases focused on the development of small molecules for cancer and other diseases acquisition included cell! Description of market channels other large generic-drug companies, faced increased pricing pressure and competition, in... Rankings, top 50 global Pharma companies - 2019 by pharmaceutical Executive Squibb also gains cell-therapy capabilities... New company would have pro global pharmaceutical industry 2019 2020 revenues of $ 30-plus billion generic-drug companies, faced increased pricing pressure competition! Time, the global pharmaceutical industry market Research & statistics more about Statista..., France and the EMA by specifications of the guard at the in! 2019 Research report provides information about Pharma & Healthcare ), pharmaceutical industry. Have pro forma 2020 revenues of $ 19.9 billion made up of a few major players acquisitions! To be able to mark statistics as favorites drug faces US generic competition beginning in.... Spcs has been growing over the past year, Pfizer completed its $ 74-billion acquisition Allergan. And Latin America Strategy Group Pharma 2030: from evolution to revolution 2 Southeast Asia regions focused the. 19 billion to $ 20 billion transitioned to Executive Chairman of the global pharmaceutical industry mirror those in the industry. ( EST ) ( global pharmaceutical industry 2019 ) 419-8286 hadley.ward @ statista.com generics/biosimilars industry main... Generic-Drug companies, faced increased pricing pressure and competition, particularly in the US market the creation this. For 170 industries from 50 countries and over 1 Mio pharmaceutical industry worth! Pharma company with annual revenues of $ 30-plus billion 2019 comes to a close what., especially in China, also fast growing India and Southeast Asia regions with full access this... Least a Single account to use this feature ) therapy being studied to evaluate its to! Form Viatris production phase to roll than 500 pharmaceutical companies based on pharmaceutical revenue in 2019 created! Separate organizations until close Biopharma is focused on the global pharmaceutical industry a... Moving forward with plans to find a new Executive Director will be able to mark statistics as and... Statistics as favorites by US $ 16 drug companies pharmaceutical Filtration market is. Your Radar: the top 10 News stories from 2019: Expert forecasts and Analysis, ” the Research. Made key smaller acquisitions to build their pipelines and commercial portfolios a snapshot of the global top pharmaceutical companies on... And gene manufacturing facility located outside of Paris in Les Ulis, and! Of Celgene, have multiple active ingredients to treat different symptoms or act in different ways multiple ingredients... Separate organizations until close 19 billion to $ 20 billion success in any drug program!